EURETINA 2024: Subretinal gene therapy improves function and structure in patients with Bothnia Dystrophy
Bothnia Dystrophy generally presents during early childhood; patients have night blindness, progressive visual loss, and subsequent legal blindness.
EURETINA 2024: Ocular involvement among patients with COVID-19 infection or vaccination
A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies
EURETINA 2024: Cardio-ocular syndrome and retinal microvasculature changes in acute heart failure
The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients
EURETINA 2024: Efficacy results and patient preference findings from the Pagoda trial
Dr Margaret A. Chang shares data on the port delivery system with ranibizumab, and her strategy for making the most of conferences
Study examines navigation performance in glaucoma with virtual-reality-based assessment of path integration
Uncertainty during everyday navigation tasks may adversely affect quality of life for patients with glaucoma
See what our Editorial Advisory Board members are bringing to EURETINA
Spotlight on the retina specialists who make up the Eye Care Network advisory boards
Industry preview: Ophthalmic companies bring updates, new research findings to EURETINA
Businesses in the retina care space tease new technologies and cutting-edge therapeutics
Celebrate World Retina Day at the 2024 EURETINA Congress
As part of the Barcelona meeting, retina specialists can recognise the awareness day early
24th EURETINA Congress: The art of retina on stage in Barcelona
Focus on collaboration, career development and innovation
Remembering a legend: EURETINA members speak about the Ramin Tadayoni Award
The Ramin Tadayoni Award supports the next generation of retina researchers while paying tribute to a leader in the field
Trinity team’s gene therapy offers promising glaucoma and AMD treatment
Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells
ESCRS 2024: Approaching a paradigm shift in cell therapy for corneal oedema and endothelial dysfunction
Michael Goldstein, MD, discusses 12-month safety and efficacy trial data of human corneal endothelial cell therapy, presented at the 2024 ESCRS Congress
iCare debuts slit-lamp-mounted ST500 tonometer
The Finnish company shared technical specifications for the ST500
ESCRS 2024: A new EDOF IOL brings functional outcomes into the spotlight
Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile
ESCRS 2024: 36-month results following femtosecond laser image-guided high precision trabeculotomy (FLigHT)
Rick Lewis, MD, speaks about a non-pharmaceutical approach to treating glaucoma with laser technology
Magnetic cell therapy for corneal endothelial dysfunction
Phase 1 multicentre study data demonstrate early signs of efficacy
Unite and conquer: Refractive surgery goes on a world tour
The ESCRS Moving Simulator initiative brings surgical training to nations in need
Filomena Ribeiro, MD, PhD, FEBO, discusses escape rooms, inclusivity initiatives and everything else ESCRS
Dr Ribeiro, President of the European Society of Cataract and Refractive Surgeons, previewed the 2024 congress
BVI announces launch of SERENITY and SERENITY Toric IOLs at ESCRS
The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family
Corneal nerve regeneration following semaglutide therapy
A case report demonstrates independent effect of GLP-1 receptor agonist
The digital OR: Retina care of tomorrow
The future of the tech-forward surgical suite
Research findings illustrate role of vitamin D in preventing retinal vein occlusion
A meta-analysis indicates a "significant association" between vitamin D deficiency and increased risk of RVO
A field guide to optic disc drusen
Clinical associations, imaging strategies and establishing a differential diagnosis from pseudopapilloedema
Rayner announces launch of RayOne Galaxy spiral IOL
The IOL, designed with artificial intelligence, will launch at this year's ESCRS Congress in Barcelona, Spain
The shifting landscape of conjunctival hyperemia
European patients navigate new therapies and market change-ups
Phase 1/2 Study suggests efficacy of novel eye drop to reverse cataracts
The drop breaks up degraded protein complexes which cause lens clouding
Research indicates long-term effect of COVID-19 on corneal endothelial cell morphology
Specular microscopy showed "long-term alterations" in corneal cells
Why the future of glaucoma care is in the operating room
Smaller surgeries, in greater numbers, await new glaucoma specialists
The CHAMP clinical trial and NVK002 for controlling paediatric myopia
Determining the medication’s safety and efficacy for paediatric patients
Ranibizumab biosimilar LUBT010 (Lupin) reaches primary endpoint in global Phase 3 study
Lupin has successfully completed a clinical study of LUBT010, a ranibizumab biosimilar to Lucentis